Exhibit 99.7

                Avocent Reports First Quarter Results

    HUNTSVILLE, Ala.--(BUSINESS WIRE)--April 21, 2005--Avocent
Corporation (NASDAQ:AVCT) today reported revenue of $76.8 million for
the first quarter ended April 1, 2005.
    "Avocent's first quarter results were consistent with the revised
revenue estimates provided in mid-March," stated John R. Cooper,
chairman and chief executive officer of Avocent Corporation. "Sales to
OEMs increased over last year, however, sales of our U.S. branded
products were lower than we originally expected due to a number of
factors we previously discussed in March. Sales activity increased
later in the quarter and we are pleased with the recovery in our
branded sales, which have moved closer to more normal levels in recent
weeks.
    "We continued to invest in research and development in the first
quarter to support new product introductions and products under
development. We recorded our first design wins that combined embedded
KVM and IPMI solutions during the quarter and believe this area holds
excellent promise for Avocent in the future. We remain positive about
our new product pipeline and the impact it will have on future sales."

    First Quarter Results

    Income prior to intangible amortization and merger-related
expenses was $7.3 million, or $0.14 per diluted share, compared with
income prior to intangible amortization and merger-related expenses of
$16.1 million, or $0.33 per diluted share, in the first quarter of
2004. (See "Use of Non-GAAP Financial Measures" discussion below.) Net
adjustments to reconcile to GAAP net income were $5.5 million in the
first quarter of 2005, including $6.6 million in intangible
amortization and a $1.8 million tax benefit. Net adjustments to
reconcile to GAAP net income were $7.6 million in the first quarter of
2004, including $4.8 million in amortization of intangible assets,
$6.5 million in acquired in-process R&D expenses and a $4.6 million
tax benefit.
    GAAP net income for the first quarter of 2005 was $1.8 million, or
$0.04 per diluted share. This compares with a GAAP net income of $8.5
million, or $0.17 per diluted share, in the first quarter of 2004.
    Net sales for the first quarter declined 10.8% to $76.8 million
compared with sales of $86.1 million in the first quarter of 2004.
Branded sales declined 27.6% from the first quarter of 2004 and
accounted for 47.8% of total sales. OEM sales rose 13.3% from the
first quarter of 2004 and accounted for 52.2% of total first quarter
2005 sales. U.S. sales declined 21.9% to $40.0 million and
international sales rose 5.6% to $36.8 million compared with the first
quarter of 2004.
    "OEM sales benefited from the contribution of embedded products,"
continued Mr. Cooper. "We believe our opportunities in this area will
continue to expand as we strengthen our embedded product suite.
International sales also increased, reflecting the investments we made
in our sales infrastructure in certain European and Asian countries."
    Gross profit for the first quarter of 2005 declined 13.0% to $43.6
million with a gross margin of 56.7%. This compared with gross profit
of $50.1 million and a gross margin of 58.2% in the first quarter of
2004. The decrease in gross profit was due to the lower sales volume.
    Research and development expenses increased 53.4% to $14.5
million, or 18.8% of sales, compared with $9.4 million, or 11.0% of
sales, in the first quarter of 2004. This increase was due primarily
to increased investments in new products, supporting new product
introductions and an increase in R&D staff to support these efforts.
    Selling, general and administrative expenses rose 9.6% to $22.3
million compared with $20.3 million in the first quarter of 2004. The
increase included higher legal costs in the first quarter to support
patent litigation scheduled for trial in the second quarter.
    Avocent's balance sheet and cash position remained strong as of
April 1, 2005. The Company's cash flow from operations was
approximately $10 million for the first quarter of 2005 with over $325
million in cash, cash equivalents and investments at the quarter's
end. Avocent had no long-term debt as of April 1, 2005.
    "We used our strong cash position to repurchase approximately
700,000 shares of Avocent's stock during the first quarter," continued
Mr. Cooper. "We have repurchased approximately one million shares to
date under the two million share repurchase authorization announced in
November 2004."

    Use of Non-GAAP Financial Measures

    Income prior to intangible amortization and merger-related
expenses, or operational income as used in the attached financial
statement schedules, is not a measure of financial performance under
generally accepted accounting principles (GAAP) and should not be
considered a substitute for or superior to GAAP. Avocent's management
uses operational income as a financial measure to evaluate performance
and allocate resources within the Company. Management believes this
measure presents the Company's results on a more comparable
operational basis by excluding non-cash amortization expenses,
non-operational expenses associated with mergers and acquisitions, and
significant and unusual non-recurring gains and losses on sales or
impairments of investments made by Avocent. Avocent believes that
operational income is a measure of performance used by some investment
banks, analysts, investors and others to make informed investment
decisions. Other companies may calculate operational income in a
different manner so this measure may not be comparable to similar
measures presented by other companies. A reconciliation of Avocent's
results using operational measures and GAAP is set forth in the
condensed consolidated statements of operations included in this press
release.

    Conference Call Information

    Avocent will provide an on-line, real-time webcast and rebroadcast
of its first quarter results conference call to be held April 21,
2005. The live broadcast will be available online at www.avocent.com
as well as www.vcall.com beginning at 10:00 a.m. central time. The
on-line replay will follow immediately and continue for 30 days.

    About Avocent Corporation

    Avocent Corporation is the leading supplier of connectivity
solutions for enterprise data centers, service providers and financial
institutions worldwide. Branded products include switching, extension,
intelligent platform management interface (IPMI), remote access and
video display solutions. Additional information is available at:
www.avocent.com.

    Forward-Looking Statements

    This press release contains statements that are forward-looking
statements as defined within the Private Securities Litigation Reform
Act of 1995. These include statements regarding the development,
introduction, features, and benefits of new products and technologies,
the size and growth of the current and future markets for these
products and technologies (including our combined embedded KVM and
IPMI solutions), and engineering and design activities. These
forward-looking statements are subject to risks and uncertainties that
could cause actual results to differ materially from the statements
made, including the risks associated with general economic conditions,
risks attributable to future product demand, sales, and expenses,
risks associated with reliance on a limited number of customers,
component suppliers, and single source components, risks associated
with acquisitions, risks associated with product design efforts and
the introduction of new products and technologies, and risks
associated with obtaining and protecting intellectual property rights.
Other factors that could cause operating and financial results to
differ are described in Avocent's annual report on Form 10-K filed
with the Securities and Exchange Commission on March 14, 2005. Other
risks may be detailed from time to time in reports to be filed with
the SEC. Avocent does not undertake any obligation to publicly update
its forward-looking statements based on events or circumstances after
the date hereof.


                         AVOCENT CORPORATION
           Condensed Consolidated Statements of Operations
           (Unaudited, in thousands, except per share data)

                                   For the Quarter Ended April 1, 2005
                                       Operational Adjustments  GAAP
                                                       (a)
                                       ----------- -------------------

Net sales                                $ 76,805            $ 76,805
Cost of sales                              33,223              33,223
                                          -------- ---------- -------
  Gross profit                             43,582              43,582

Research and development expenses          14,176    $    291  14,467
Selling, general and administrative
 expenses                                  21,903         377  22,280
Amortization of intangible assets               -       6,622   6,622
                                          --------    -------- -------
  Operating income                          7,503      (7,290)    213

Other income (expense), net                 1,955         (15)  1,940
                                          --------    -------- -------
Income before provision for income
 taxes                                      9,458      (7,305)  2,153

Provision for income taxes                  2,137      (1,818)    319
                                          --------    -------- -------
Net income                               $  7,321    $ (5,487)$ 1,834
                                          ========    ======== =======

Earnings per share:
  Basic                                  $   0.15            $  0.04
  Diluted                                $   0.14            $  0.04

Weighted average shares and common equivalents
 outstanding:
  Basic                                    50,208           -  50,208
  Diluted                                  51,510         (58) 51,452


                                   For the Quarter Ended April 2, 2004
                                       Operational Adjustments  GAAP
                                                       (a)
                                       ----------- -------------------

Net sales                                $ 86,085             $86,085
Cost of sales                              35,888    $     95  35,983
                                          --------    -------- -------
  Gross profit                             50,197         (95) 50,102

Research and development expenses           9,254         174   9,428
Acquired in-process research and
 development expense                            -       6,490   6,490
Selling, general and administrative
 expenses                                  19,725         610  20,335
Amortization of intangible assets               -       4,762   4,762
                                          --------    -------- -------
  Operating income                         21,218     (12,131)  9,087

Other income (expense), net                 1,151         (14)  1,137
                                          --------    -------- -------
Income before provision for income
 taxes                                     22,369     (12,145) 10,224

Provision for income taxes                  6,253      (4,572)  1,681
                                          --------    -------- -------
Net income                               $ 16,116    $ (7,573)$ 8,543
                                          ========    ======== =======

Earnings per share:
  Basic                                  $   0.34            $  0.18
  Diluted                                $   0.33            $  0.17

Weighted average shares and common equivalents
 outstanding:
  Basic                                    47,650           -  47,650
  Diluted                                  49,538         (25) 49,513

(a) Note: Adjustments relate to acquired in-process research and
    development expense from the Crystal link acquisition and
    amortization of deferred compensation (from the capitalization of
    the value of stock options assumed) and intangibles recorded as
    the result of the merger of Apex and Cybex in July 2000 and the
    acquisitions of Equinox, 2C, Soronti, Crystal Link, OSA and Sonic
    Mobility. The calculation of weighted average shares and common
    equivalents outstanding differs due to excluding the average
    unamortized deferred compensation expense in calculating the
    operational diluted shares outstanding.


                         AVOCENT CORPORATION
                Condensed Consolidated Balance Sheets
                        (Dollars in thousands)

                                               April 1,   December 31,
                                                2005         2004
                                             (Unaudited)  (Unaudited)
                                             ------------ ------------

Cash, cash equivalents
  and short-term investments                    $241,346     $239,799
Accounts receivable, net                          50,034       60,948
Current and deferred income tax receivable         6,134        7,095
Other receivables, net                               397          566
Inventories, net                                  24,316       21,232
Other current assets                               6,788        4,982
                                             ------------ ------------
  Total current assets                           329,015      334,622

Investments                                       84,127       91,547
Property and equipment, net                       39,328       39,896
Goodwill                                         270,001      269,892
Intangible assets, net                            27,421       33,981
Other assets                                         887          843
                                             ------------ ------------
Total assets                                    $750,779     $770,781
                                             ============ ============


Accounts payable and other accrued expenses      $15,200      $21,368
Income tax payable                                 8,356        8,494
Other current liabilities                         16,515       16,767
                                             ------------ ------------
  Total current liabilities                       40,071       46,629

Non-current liabilities                            7,712       10,855

Total stockholders' equity                       702,996      713,297

                                             ------------ ------------
Total liabilities and stockholders' equity      $750,779     $770,781
                                             ============ ============

    CONTACT: Avocent Corporation
             Dusty Pritchett, 256-217-1300